Vantage Oncology - Board Members

Board Members

Michael T. Fiore – Chief Executive Officer and Co-Founder

Mr. Fiore founded Vantage Oncology in 2002 in collaboration with Dr. Leslie Botnick. He has more than 25 years of experience in the development and operation of cancer treatment facilities. Mr. Fiore and his team have successfully grown Vantage into a national organization. In January 2011, Vantage completed an equity recapitalization with Oak Hill Capital Partners and a merger with Physician Oncology Services, creating the second largest radiation oncology company in the United States.

Mr. Fiore was previously the COO of Salick Health Care, a publicly traded cancer and dialysis services company with over 30 sites, and President of its cancer center subsidiary, prior to its successful sale to Astra Zeneca in 1997. He has also served as CEO of InterDent, an owner and operator of 350 dental facilities throughout the United States, and as Vice President of American Medical International (now Tenet Healthcare), an owner and operator of hospitals. Mr. Fiore is a Director of the Cancer Support Community - South Bay Cities, a non-profit organization that provides a professional program of support, education and hope to cancer patients and their families free of charge. Mr. Fiore has a MBA from Harvard University, a BA in Economics and Anthropology from Amherst College and an MS in Accounting from New York University. He is a Certified Public Accountant. Mr. Fiore was named a 2010 Ernst & Young Entrepreneur of the Year Award Winner for the Greater Los Angeles Area.

Leslie E. Botnick, MD – Chief Medical Officer and Co-Founder

A board certified Radiation Oncologist practicing at The Center for Radiation Therapy of Beverly Hills, Dr. Botnick is Co-Founder and Chief Medical Officer of Vantage Oncology. In addition, he is the Chief Executive Officer and Founder of Valley Radiotherapy Associates Medical Group. Previously at the Beth Israel Hospital in Boston, Dr. Botnick was Medical Director of Radiation Oncology.

With more than 40 publications on Breast Cancer, Hodgkin’s disease, Head and Neck Cancer and Hematopoietic Stem Cell Repair, he is named as a leading physician for the treatment of Breast Cancer in Good Housekeeping Magazine and listed in Who’s Who of Doctors in America. In addition, Dr. Botnick is associated with several Health Systems throughout Los Angeles, Orange and Riverside counties in California, including the nationally renowned John Wayne Cancer Institute. His areas of expertise include: Breast, Prostate, Lung, Head and Neck, Pancreatic, and Colorectal Cancer as well as Hodgkin’s and Non-Hodgkin’s Lymphoma.

At Metropolitan Hospital in New York, he served an internship in internal medicine and did his residency at the Harvard Joint Center for Radiation Therapy in Boston where he later became Chief Resident. Dr. Botnick earned a Bachelors of Arts Degree from Brooklyn College followed by a Medical Degree from New York Medical College.

Michael E. Aspinwall - Managing Partner, CCP Equity Partners

A Managing Partner with CCP Equity Partners, Mr. Aspinwall specializes in healthcare services, specialty managed care, disease management and healthcare information technologies as well as related outsourcing services. Prior to joining CCP Equity Partners, he was Senior Vice President and Co-Head of Healthcare Investing at GE Equity, General Electric's private equity business, and a Managing Partner of Bear Stearns Health Innoventures. Mr. Aspinwall earned a MBA from the University Of Chicago Graduate School Of Business and holds a Bachelor of Science from Worcester Polytechnic Institute.

Harry L. Eichelberger - Principal, Oak Hill Capital Partners

A Principal of Oak Hill Capital Partners, Mr. Eichelberger is responsible for investments in the Healthcare group. Prior to joining Oak Hill in 2003, he worked at JPMorgan in its financial sponsors group. Mr. Eichelberger earned a Bachelors of Science degree and a Bachelor of Arts degree with high honors from the University of California, Berkeley.

Steven B. Gruber - Managing Partner, Oak Hill Capital Partners

A Managing Partner of Oak Hill Capital Partners since 1990, Mr. Gruber has senior responsibility for originating, structuring and managing investments for the firm's Healthcare and Business and Financial Services industry groups. Prior to joining Oak Hill, Mr. Gruber was a Managing Director and Co-Head of High Yield Securities at Lehman Brothers and a Managing Director of its merchant banking group, as well as a member of the Lehman Brothers Investment Committee. He earned a Bachelors of Arts from the University of Michigan and a MBA from the University Of Chicago Graduate School Of Business, where he was a Merrill Fellow.

Mark Pacala – Operating Consultant, Oak Hill Capital Partners

Mark Pacala serves as an Operating Consultant to Oak Hill Capital Partners with respect to companies in the Healthcare sector. Formerly he served as CEO of American WholeHealth and as General Partner at Essex Woodlands. Prior to that, he served as the CEO of Forum Group, a public senior housing and healthcare company and as a Senior Vice President and General Manager at the Walt Disney Company, where he founded the Disney Vacation Club. Mr. Pacala holds a Bachelor of Arts from Hamilton College, where he graduated magna cum laude and Phi Beta Kappa, and an M.B.A. from Harvard Business School.

Charles B. Patton - Partner, Oak Hill Capital Partners

A Partner of Oak Hill Capital Partners, Mr. Patton has been with the firm since 2001. He is responsible for originating, structuring and managing investments in the Healthcare group. Prior to joining Oak Hill, he was a Vice President with Morgan Stanley Capital Partners. Mr. Patton also worked in Morgan Stanley's Mergers, Acquisitions and Restructuring and Private Investment departments. Mr. Patton earned a Bachelor of Science degree from the University of California, Berkeley and a MBA from Harvard Business School.

David Ward – General Partner, Salix Ventures

Mr. Ward co-founded Salix Ventures, a prominent healthcare venture capital firm in 1997. Prior to Salix, he was instrumental in the start-up and growth of two companies, MedCath and MediVision. As Vice President of Development at MedCath (Nasdaq:MDTH), a cardiovascular services provider, he was instrumental in conceiving, planning, and executing the company's strategy for developing specialty heart hospitals - the first independent, freestanding specialized facilities in the United States dedicated to cardiovascular care. At Bain Capital, where he began his career, Mr. Ward was part of a team that conceived, developed, and implemented the business plan for MediVision. Mr. Ward received his J.D. and M.B.A. from Stanford University in 1983 and graduated Phi Beta Kappa from Stanford University in 1979 with an A.B. in economics.